DEVELOPMENT OF A NOVEL PLATFORM FOR IN VIVO DELIVERY OF ANTAGOMIRS TO STUDY CETUXIMAB RESISTANCE IN COLORECTAL CANCER

The Research Foundation For The State University Of New York

Investigators